Skip to content

Solid Biosciences Inc. SLDB Ratios & Valuation

FY'25FY'24FY'23FY'22
Returns
Return on equity-109.9%-15.3pp-94.6%-37.8pp-56.8%-15.8pp-41%+1.5pp
Return on assets-82.8%-12.2pp-70.5%-25.4pp-45.2%-10.3pp-34.9%+0.9pp
Return on invested capital-161.1%+1.1pp-162.2%-34.8pp-127.5%-6.6pp-120.8%
Liquidity
Current ratio6.1×+0.9×5.2×-3.7×8.9×-0.8×9.8×+0.3×
Quick ratio6.1×+0.9×5.2×-3.7×8.9×-0.8×9.8×+0.3×
Cash ratio1.8×-0.9×2.7×-2.4×5.1×-1.8×6.9×+1.9×
Leverage
Debt-to-equity0.1×-0.1×0.2×0.0×0.2×+0.1×0.1×+0.1×
Debt-to-assets0.1×0.0×0.1×0.0×0.2×0.0×0.1×+0.1×
Per Share
Book value per share$2.06-38.8%$3.36-47.1%$6.36-74.4%$24.87-15.0%
Valuation
Market capitalization$910.66M+135%$159.82M+29.0%$123.89M+17.9%$105.06M-45.6%
Enterprise value$634.23M+223%$103.76M+36.3%$76.14M+450%-$21.78M-129%
Price / book2.3×+1.1×1.2×+0.2×+0.5×0.5×-0.4×
Free cash flow yield-19.8%+9.1pp-63%+14.3pp-77.2%+18.9pp-96.1%-55.2pp
Earnings yield-22%+15.6pp-78%-0.5pp-77.5%+4.3pp-81.8%-44.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Solid Biosciences Inc.'s ratios come from?
Every ratio is computed from Solid Biosciences Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.